Transferrin–Liposome-Mediated p53 Sensitization of Squamous Cell Carcinoma of the Head and Neck to Radiation In Vitro

Publisher Website
Google Scholar
Abstract
Wild-type (wt) p53 DNA was transfected into the radioresistant human cell line JSQ-3, established from a squamous cell carcinoma of the head and neck (SCCHN), using a transferrin–liposome system, and the ability of the introduced wt p53 to sensitize the transfected JSQ-3 cells to ionizing radiation was examined. Transferrin increased the in vitro transfection efficiency of cationic liposomes up to 70–80% in JSQ-3 cells, representing a 6- to 10-fold increase over liposome transfection alone. The exogenous wt p53 was expressed at high levels in transferrin–liposome–DNA-transfected cells and resulted in the reversion of the radioresistant phenotype of the JSQ-3 cells in a DNA dose-dependent manner. The D10 values were reduced from 6.36 ± 0.54 Gy to 4.13 ± 0.06 Gy, a value in the radiosensitive range. In vivo, the intratumoral injection of the transferrin–liposome system resulted in a higher number of transfected tumor cells in the JSQ-3 induced nude mouse xenografts when compared with transfection by liposome alone. The results indicate that the combination of p53 replacement gene transduction, mediated by the relatively safe transferrin–liposome system, and conventional ionizing radiation may provide a more effective treatment for head and neck cancer. High-level wild-type p53 gene transfer and expression was observed in JSQ-3 cells transfected with a relatively efficient transferrin–liposome system, and the radioresistance of the cells in vitro was lowered to the radiosensitive range in a DNA dose-dependent manner.